Literature DB >> 3458949

Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice.

K Suzuki, W R Bruce.   

Abstract

Intrarectal exposure of the colon epithelium of the C57BL/6J female mouse to deoxycholic acid [(DCA) CAS: 83-44-3] markedly increased its sensitivity to orally administered 1,2-dimethylhydrazine [(DMH) CAS: 540-73-8]. While 4 mg DMH/kg body weight by itself increased the level of nuclear damage from a background level of 0.2-0.45 aberration per crypt, DMH when combined with DCA at a dose of 150 mg/kg increased the aberrations from 0.2 to 1.75 per crypt. This effect was observed over a wide range of DCA doses (20-300 mg/kg) and was evident when DMH was given up to 10 hours after the DCA. Similar results were observed with DCA in conjunction with benzo[a]pyrene (CAS: 50-32-8) and 2-amino-3,4-dimethylimidazo(4,5-f)quinoline (CAS: 77094-11-2), though in these cases the time at which the peak of nuclear aberrations occurred was somewhat later. No enhancement was seen with DCA and gamma-radiation. These results show that DCA can enhance the nucleotoxic effects of several carcinogens and suggest that DCA can act as a cocarcinogen. The enhancement may be due to the effect of the bile acid on proliferation of the colon epithelial cells or to its effect on the permeability of mucosal cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458949

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  2 in total

Review 1.  Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Christos Tsaitas; Anysia Semertzidou; Emmanouil Sinakos
Journal:  World J Hepatol       Date:  2014-04-27

2.  Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer.

Authors:  Shinichi Yachida; Sayaka Mizutani; Hirotsugu Shiroma; Satoshi Shiba; Takeshi Nakajima; Taku Sakamoto; Hikaru Watanabe; Keigo Masuda; Yuichiro Nishimoto; Masaru Kubo; Fumie Hosoda; Hirofumi Rokutan; Minori Matsumoto; Hiroyuki Takamaru; Masayoshi Yamada; Takahisa Matsuda; Motoki Iwasaki; Taiki Yamaji; Tatsuo Yachida; Tomoyoshi Soga; Ken Kurokawa; Atsushi Toyoda; Yoshitoshi Ogura; Tetsuya Hayashi; Masanori Hatakeyama; Hitoshi Nakagama; Yutaka Saito; Shinji Fukuda; Tatsuhiro Shibata; Takuji Yamada
Journal:  Nat Med       Date:  2019-06-06       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.